0001932193-24-000001.txt : 20241009 0001932193-24-000001.hdr.sgml : 20241009 20241009131234 ACCESSION NUMBER: 0001932193-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241009 DATE AS OF CHANGE: 20241009 EFFECTIVENESS DATE: 20241009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RS BioTherapeutics Inc. CENTRAL INDEX KEY: 0001932193 ORGANIZATION NAME: IRS NUMBER: 880778666 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-526303 FILM NUMBER: 241362237 BUSINESS ADDRESS: STREET 1: 157 BALTIMORE STREET CITY: CUMBERLAND STATE: MD ZIP: 21502 BUSINESS PHONE: 717.433.5390 MAIL ADDRESS: STREET 1: 157 BALTIMORE ST. SUITE 140 CITY: CUMBERLAND STATE: MD ZIP: 21502 D 1 primary_doc.xml X0708 D LIVE 0001932193 RS BioTherapeutics Inc. 157 BALTIMORE STREET CUMBERLAND MD MARYLAND 21502 717.433.5390 DELAWARE None None Corporation true 2021 Curtis Rhine 157 Baltimore Street Cumberland MD MARYLAND 21502 Executive Officer H. Dean Hart 157 Baltimore Street Cumberland MD MARYLAND 21502 Executive Officer David Freas 157 Baltimore Street Cumberland MD MARYLAND 21502 Director Justin Molignoni 157 Baltimore Street Cumberland MD MARYLAND 21502 Executive Officer Director Michael Guzman 157 Baltimore Street Cumberland MD MARYLAND 21502 Executive Officer Other Health Care Decline to Disclose 06b false 2024-09-26 false true true Simple Agreement for Future Equity false 0 2000000 20000 1980000 false 1 0 0 0 false RS BioTherapeutics Inc. /s/ Curtis Rhine Curtis Rhine Chief Financial Officer 2024-10-09